Anti-inflammatory isocoumarins from the bark of Fraxinus chinensis subsp. rhynchophylla

Nat Prod Res. 2021 Nov;35(22):4380-4387. doi: 10.1080/14786419.2020.1715401. Epub 2020 Jan 21.

Abstract

A new isocoumarin (1) named fraxicoumarin was isolated from the bark of Fraxinus chinensis subsp. rhynchophylla along with three known compounds (2-4). The structure of the new compound was established by extensive spectroscopic studies and chemical evidence. The anti-inflammatory effects of the isolated compounds (1-4) on lipopolysaccharide (LPS)-induced RAW 264.7 macrophage cells were evaluated in vitro. Of the compounds tested, compounds 1 and 3 inhibited LPS-induced nitric oxide (NO) production in RAW 264.7 cells. Consistent with these findings, they also suppressed LPS-induced expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) at the protein level in RAW 264.7 cells.

Keywords: Fraxinus chinensis subsp. rhynchophylla; anti-inflammation; cyclooxygenase-2; inducible nitric oxide synthase; isocoumarins; nitric oxide.

MeSH terms

  • Anti-Inflammatory Agents / pharmacology
  • Cyclooxygenase 2 / metabolism
  • Fraxinus*
  • Isocoumarins / pharmacology
  • Lipopolysaccharides / pharmacology
  • Nitric Oxide / metabolism
  • Nitric Oxide Synthase Type II / metabolism
  • Plant Bark

Substances

  • Anti-Inflammatory Agents
  • Isocoumarins
  • Lipopolysaccharides
  • Nitric Oxide
  • Nitric Oxide Synthase Type II
  • Cyclooxygenase 2